A major goal of personalized anti-cancer therapy is to increase the drug e®ects while reducing the side e®ects as much as possible. A novel therapeutic strategy called synthetic lethality (SL) provides a great opportunity to achieve this goal. SL arises if mutations of both genes lead to cell death while mutation of either single gene does not. Hence, the SL partner of a gene mutated only in cancer cells could be a promising drug target, and the identi¯cation of SL pairs of genes is of great signi¯cance in pharmaceutical industry. In this paper, we propose a hybridized method to predict SL pairs of genes. We combine a data-driven model with knowledge of signalling pathways to simulate the in°uence of single gene knock-down and double genes knock-down to cell death. A pair of genes is considered as an SL candidate when double knock-down increases the probability of cell death signi¯cantly, but single knock-down does not. The single gene knock-down is con¯rmed according to the human essential genes database. Our validation against literatures shows that the predicted SL candidates agree well with wet-lab experiments. A few novel reliable SL candidates are also predicted by our model.
Introduction
A major challenge to establish treatments for human cancer is how to kill cancer cells speci¯cally, but spare normal cells. Among the developed anti-cancer ‡ ‡ Corresponding author. therapies, the lack of selectivity of the drugs is likely to lead to the elimination of both the tumour and the healthy cells, thus causing various side e®ects. To improve the classic cytotoxic therapies, a novel anti-cancer strategy named synthetic lethality (SL) 1 has been introduced and has shown great potential to increase the selectivity of the drugs. Two genes have SL relationship when the combination of mutations is able to kill a cell, whereas the mutation by one gene cannot. Since a lot more genetic mutations exist in tumour cells than in normal cells, the identi¯cation of the SL pair of genes could play an important role in pharmaceutical industry when one of the genes is a cancer-speci¯c mutated gene. The drug that targets the partner gene is thus able to give rise to SL and kill the tumour cells selectively.
However, the majority of the established SL identi¯cation techniques, such as RNA interference (RNAi), 2 are faced with multiple issues like the design of an e®ective small interfering RNA (siRNA) sequence and the stability across di®erent platforms or cancer subtypes. Moreover, while the underlying mechanisms that lead to SL are crucial for developing reliable anti-cancer therapies, they can hardly be re°ected by the screening-based methods. Wu et al. 3 proposed a meta-analysis datamining method that was able to predict SL based on genomic and proteomic features, Güell et al. 4 also proposed a computational method to screen synthetic lethal reaction pairs from the perspective of metabolism, however, their results mainly focused on yeast. Another computational method was developed by Heiskanen and Aittokallio, 5 which infers human SL from yeast SL based on the conserved features between the two species. However, key features that are speci¯c to human were likely to be lost.
In this paper, we propose a computational method to predict SL pairs of genes by combining a data-driven model 6, 7 with knowledge of the underlying mechanisms (e.g. signaling pathways information). The data-driven model is used to construct a function that describes the relationship between the activities of signaling proteins and the probability of cell death. Then the single gene knock-down and the double gene knock-down are simulated by taking into account the pathway information as well (e.g. what downstream proteins should be a®ected by the knock-down events). A predicted probability of cell death is calculated after gene knock-down. A pair of genes is considered as an SL candidate when the predicted probability of cell death after double genes knock-down is highly increased compared with real data, while the predictions after the knock-down of either single gene are not. We use human essential genes to validate the simulation of single gene knock-down. The Syn-Lethality database, 8 which consists of 113 SL pairs manually collected from literatures of wet-lab experiments, is employed to evaluate the SL predictions of our model. The two SL pairs of genes that coexist in the Syn-Lethality database and in the employed data set are successfully identi¯ed. Explanations of the mechanisms of the novel predicted SL pairs of genes are also presented.
Methods

Data
We downloaded the time-series signaling data for proteins from the work of Lee et al. 9 This signaling data set contains the phosphorylation levels of 32 signaling proteins at 5 time points, as well as the cell fates (e.g., apoptosis, proliferation) measured using°ow cytometry at the corresponding time points. In addition, the signaling data contains six treatments (i.e. six groups), which were designed on breast cancer cells (e.g. cell line BT20). We chose the control group (treated with DMSO) data since the other¯ve groups had been treated by di®erent drugs which may introduce unpredictable biases to our model. For each signalling protein, the values of its phosphorylation levels from all the biological experiments were normalized into an open interval between 0 and 1. Suppose max and min represent the maximum and minimum measurements of a protein, respectively, then for every biological measurement (denoted as mea) of this protein, the normalized value is ðmea À min Ã 0:99Þ=ðmax Ã 1:01 À min Ã 0:99Þ. Finally, we approximately estimated the probability of cell death as the proportion of dead cells under each treatment.
Pathways
Pathway information was extracted from GeneGO database. 10 Classic signaling pathways about the regulation of cell fates (e.g. apoptosis and proliferation) were extracted and combined into a network as shown in Fig. 1 . Here, we constructed a generic pathway where only the proteins with phosphorylation measurements available in the data set and their direct interaction neighbors were retained. In this generic pathway, there are 59 signaling proteins and three cell fates (i.e. apoptosis, proliferation, cell cycle). And among the 59 proteins, 28 had measurements in the data set we downloaded, i.e. SMAC, 4EBP1, Beclin1, H2AX, ERK, S6, S6K, Cabl, Casp6, Casp9, CDC25, Chk1, p27, PUMA, Wee1, HSP27, AKT, JNK, p38, BIM, BID, DAPK1, CYCLIND1, STAT3, p53, Casp8, EGFR and HER2 (green nodes in Fig. 1 ).
Data-driven model
We¯rst constructed a mathematical model in Eq. (1) 7 to relate the cell signals to the cell fates. At each time point, P is the probability of cell death, x i (where i ¼ 1; . . . ; 28) represents the activity (e.g. phosphorylation level) of the ith signaling protein, i indicates the in°uence of the corresponding protein to the cell death (as such, it is not propagation through the network, but rather direct regression to the target node, i.e. apoptosis) and " is a small constant representing random error. Next, we built the functions in Eq. (2) 7 to describe the relationship between a signaling protein and all its measured upstream nodes in Fig. 1 . For each signalling protein (e.g. the ith protein), we selected it as the dependent variable in Eq. (2) and all its measured upstream nodes as independent variables, with ij representing the contribution of the jth measured upstream node to the node i and all the parameters forming a matrix M. To identify the upstream nodes of the node i, we considered not only its direct parent nodes, but also the measured proteins that had at least one path leading to the node i. For example, from Fig. 1 , we can see that SMAC has two direct parent nodes (JNK and BAX, but only JNK has measurements), and since there is a path BIM-BAX-SMAC and BIM has measurements, both JNK and BIM will be considered as the measured upstream nodes of SMAC.
Then the parameters in Eqs. (1) and (2) (e.g. i and ij ) were learnt using partial least squares regression (PLSR) method as in our previous work 7 based on the data set (Algorithms 1 and 2).
Gene knock-down simulation
Suppose that the signalling protein u is a measured upstream node of protein v in our generic pathway, and u is knocked down (e.g. mutated or blocked). The signals received by v are thus changed under the assumption that all the other upstream nodes of v remain unchanged. For example, v will be downregulated or upregulated after the removal of u when u activates or inhibits v, respectively. Assuming that u is knocked down, we next estimate the changes of its measured downstream nodes and the corresponding probability of cell death, based on our data-driven models in Eqs. (1) and (2).
Algorithm 1. Learning parameters of Eq. (1).
INPUT: Time-series signalling protein data X (t×n) and cell death data P t×1 , where t is the number of measurements and n = 28.
OUTPUT:
The vector A : (α 0 , α 1 , ..., α n ) with n + 1 elements.
//Take the logarithm of Equation (1) . //Take the logarithm of Equation (2) ln( For the knock-down of a single gene (gene and protein are used interchangeably in this paper), we removed not only its contribution to the cell death, but also its in°uence on all its downstream nodes. For example, the jth node in the pathway was knocked down, and the e®ect of its knock-down on cell death was estimated as follows. First, we removed the in°uence of the jth protein to all its measured downstream nodes by setting the jth column in Matrix M to be 0 ( ij ¼ 0, for all i) and recalculated the activity levels of its downstream nodes. Second, we set j ¼ 0 to remove the contribution of the jth protein to cell death. Then we estimated the probability of cell death by substituting the updated protein data and vector ð 0 ; 1 ; . . . ; n Þ into Eq. (1). Fourth, we employed the Kullback-Leibler divergence (the relative entropy, given in Eq. (3)) to estimate how much the cell death predictions di®er from biological experimental measurements, where t is the number of predictions (or measurements). In information theory, the Kullback-Leibler divergence is a measure of the di®erence between two probability distributions. Algorithm 3 gives the pseudocode of the process. We de¯ned the divergence as the \single knock-down score" of the jth protein. If the single knock-down score was equal to zero, there was no increment of cell death due to knock-down event. Therefore, the bigger the single knock-down score is, the greater the cell death is promoted. 
Similarly, we can infer the e®ect on cell death when we knocked down a pair of genes. For each protein, we extracted the set of its downstream nodes. Given a pair of proteins to be knocked down, we¯rst computed the union set of their downstream nodes and recalculated the activity levels for the nodes in this union set by modifying the parameters in Eq. (2) to be 0. Then, we estimated the probability of cell death by feeding the updated activity levels and vector ð 0 ; 1 ; . . . ; n Þ to Eq. (1), and similarly used Eq. (3) to de¯ne the \double knock-down score" to measure the e®ect of the knock-down of a pair of genes.
Prediction of SL
For a protein pair ðu; vÞ, let dðu; vÞ denotes its double knock-down score. sðuÞ and sðvÞ are the single knock-down scores for u and v, respectively. Our assumption was that a protein pair ðu; vÞ with large dðu; vÞ and low sðuÞ and sðvÞ tended to be a SL pair. Hence, we de¯ned the SL score for the protein pair ðu; vÞ as in Eq. (4), to quantify their mutual dependence on knock-down events. For example, if u and v are independent, then knocking down u does not give any in°uence on knock-down of v and vice versa, so their SL score is zero. The log-ratio term (lnð dðu;vÞ sðuÞÂsðvÞ Þ) helps to identify the pairs whose double knock-down score increases signi¯cantly compared with single knock-down score. However, large log-ratio is insu±cient to clarify the discovery of an SL candidate since an SL candidate should have a large double knock-down score in the¯rst place. Therefore, by timing the double knock-down score(dðu; vÞ), the pairs with large log-ratio but small double knock-down score (such that the SL score is small) are¯ltered out to reduce the false positive. The larger the SL score is, the more likely the pair is considered as SL candidate in this paper.
SLðu; vÞ ¼ dðu; vÞ ln dðu; vÞ sðuÞ Â sðvÞ : ð4Þ Recalculate the activity levels of protein i by substituting the matrix X and rowM (i) into Equation (2);
Update the i-th column of X using the recalculate activity levels of protein i;
end for
A ← A;
Recalculate the probability of cell death by substituting the matrix X and the vector A into Equation (1); Use Equation (3) to calculate the Kullback Leibler divergence between the predicted and measured cell death as the knock-down score of protein j;
Return List of single knock-down scores for all genes.
Results
Single knock-down and essential genes prediction
To evaluate the performance of single gene knock-down simulation, 28 measured signaling proteins were ranked according to their single knock-down scores. Out of these 28 proteins, 15 proteins had single knock-down scores larger than 0. Table 1 shows the top-¯ve proteins (i.e. AKT, p53, CHK1, S6K and CYCLIND1), whose removal brings the highest impact on the probability of cell death. AKT, which is also known as Protein kinase B (PKB), plays an important role in many regulation processes such as proliferation, apoptosis, cell cycle and metabolism. From Fig. 1 , we can see that the activation of mTOR by AKT contributes to cell proliferation. AKT regulates also cell apoptosis via several pathways such as AKT-Caps9, and controls cell cycle by phosphorylating its substrates including GSK3. 11 The tumor suppressor p53 is able to induce cell cycle arrest, initiate DNA repair process when DNA is damaged and activate cell apoptosis if DNA is irreparable. Therefore, it is crucial in multiple cellular mechanisms. [12] [13] [14] CHK1, which is also referred to as checkpoint kinase 1, responds to checkpoint-mediated cell cycle arrest and DNA damage.
15 S6K (Ribosomal protein S6 kinase beta-1), which responds to mTOR and growth factors, is responsible for regulating protein synthesis, cell growth and cell proliferation. 16 CYCLIND1, acting as the regulator of cyclin-dependent kinase (CDK), belongs to a family whose members have a significant periodicity in their abundance over cell cycle. 17 Moreover, all these¯ve genes were identi¯ed as human essential genes in Online GEne Essentiality database (OGEE). 18 
Double knock-down and SL prediction
We performed double knock-down simulation over all the 378 protein pairs (i.e. 28 2 À Á as we had 28 measured signaling proteins). 252 of them had double knock-down scores larger than 0, indicating that the double knock-down event tended to increase the probability of cell death. SL scores were calculated based on Eq. (4). Table 2 gives the top 20 pairs of SL candidates after ranking based on the SL scores. A recent work has investigated the SL interactions in the signalling pathways related to DNA damage and checkpoint control. 19 Two pairs, ðp53; CHK1Þ, as well as ðp53; Wee1Þ were reported as SL pairs in their work, and these two pairs are ranked the seventh and the eleventh by our method. As reported by Kaelin 2 and Le Meur et al., 20 three types of mechanisms were proposed, from the perspectives of signalling pathways, that could be the candidate explanations of SL interactions in human cancers. First, two proteins that coexist in a linear essential pathway are likely to have SL interaction, such as ðAKT ; BIDÞ in the cascade AKT-BID-BAX-Casp9 and ðAKT ; BIMÞ in the pathway AKT-FOXO3A-BIM-BAX-Casp9 (Fig. 1) . The mutation of the¯rst protein (e.g. AKT) would decrease the signals transmitted in the pathway whereas the mutation of both destroys the pathway. Second, two proteins from two parallel essential pathways could be SL partners when they are backups of each other. For example, ðp53; CablÞ is predicted since p53 and Cabl are in two parallel essential pathways, i.e. ATM-CHK1-p53-PUMA-BAX and ATM-Cabl-BAX, respectively. Another example is ðp53; Wee1Þ, where p53 is in the pathway BRCA1-p53-CDK1 and Wee1 is in the pathway BRCA1-Wee1-CDK1. Third, two components have the same essential function or they both contribute to the construction of an essential protein complexes. Moveover, according to the Syn-Lethality database, 8 only two SL pairs of proteins reported in the literatures have measurements in the data set 9 i.e. ðp53; CHK1Þ and ðp53; Wee1Þ, and both of them have been successfully predicted by our method. 
Discussion and Conclusion
Anti-cancer therapy based on SL strategy shows great potential for its capability of treating the cancer and the normal cells di®erently. Finding SL pairs of genes provides great opportunities for drug target identi¯cation if one of the genes in the pair has been mutated in the cancer cells. However, due to the high cost of the screening technology, highly reliable results generated from wet-lab experiments are growing slowly. Therefore, we proposed a computational method which hybridizes a datadriven model with knowledge of signalling pathways to predict potential SL pairs of genes. We¯rst related the activities of signalling proteins to the probability of cell death using a mathematical function. Second, we identi¯ed the relationship between each protein and all its measured upstream nodes based on both the biological experimental data and the signalling pathways. Next we simulated the single knockdown of each measured protein and the double knock-down of all possible pairs of proteins, to estimate the signi¯cance of knock-down events to cell death. We then de¯ned the SL score to do virtual screening for the candidates of SL pairs of genes. The single knock-down simulations were con¯rmed according to the human essential genes. And the double knock-down simulations gave both wet-lab con¯rmed results and novel predictions which are suggested to be reliable by evidence from literatures. In spite of promising performance of our proposed method, limitations have been noticed which point to our future work. First, due to the lack of information, underlying mechanisms are insu±ciently considered. For example, the interaction types (e.g. phosphorylation and transcription regulation) in Fig. 1 are unclear. Also the interaction between two proteins could be activation in one cell type while inhibition under other circumstance due to di®erent genetic contexts. Second, some wellestablished network models such as Boolean network and ODE-based model should be involved to gain better performance and mechanistic understanding. And we believe that by employing these models, our method will be improved.
